Boston, MA, United States of America

Piero Anversa

USPTO Granted Patents = 19 

 

Average Co-Inventor Count = 1.7

ph-index = 5

Forward Citations = 133(Granted Patents)


Location History:

  • Boston, MA (US) (2012 - 2017)
  • New York, NY (US) (2009 - 2022)

Company Filing History:


Years Active: 2009-2022

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Piero Anversa: A Pioneer in Stem Cell Research

Introduction: Piero Anversa is a prominent figure in the field of regenerative medicine, based in Boston, MA. With a remarkable portfolio of 19 patents, he has significantly contributed to advancements in stem cell research, specifically focusing on pancreatic and cardiac applications. His innovative work has opened new avenues for treating complex health issues associated with these vital organs.

Latest Patents: Among his latest patents, Anversa has made notable strides in the areas of pancreatic stem cells and cardiac disease treatment. His patent titled "Pancreatic stem cells and uses thereof" details the therapeutic applications of c-kit positive pancreatic stem cells in preventing and treating pancreatic diseases and disorders. Additionally, he has developed methods, compositions, and kits for treating cardiac stem cells, aimed at addressing conditions such as heart failure, myocardial infarction, and age-related cardiomyopathy.

Career Highlights: Piero Anversa's career reflects a dedication to scientific innovation. He has held key positions at various institutions, including New York Medical College and Aal Scientifics, Inc. His research has not only advanced the understanding of stem cell functionality but has also contributed to practical methodologies for clinical applications. Anversa's work has also been featured in numerous scientific publications and conferences, emphasizing his influence in the regenerative medicine community.

Collaborations: Throughout his career, Anversa has collaborated with esteemed colleagues such as Annarosa Leri and Jan Kajstura. These partnerships highlight the importance of teamwork in research, leading to significant advancements in the understanding and application of stem cells in medical therapies.

Conclusion: Piero Anversa's contributions to stem cell research have positioned him as a leading innovator in the field. His patents, particularly in pancreatic and cardiac applications, exemplify the potential of stem cells to transform treatment methodologies for serious health conditions. As research continues to evolve, Anversa’s pioneering efforts will undoubtedly leave a lasting impact on regenerative medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…